Drug Trial Radar · NCT07235917
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
34
Planned (sponsor's estimate)
Start
Mar 11, 2026
Primary completion
Jan 28, 2028
Study completion May 17, 2028
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Nov 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called mibavademab (also called "study drug"). The study is focused on participants with a condition called Functional Hypothalamic Amenorrhea (FHA). FHA is a condition where a woman stops menstruating because the brain is not sending the correct hormonal signals to the ovaries, which then are not able to cycle and ovulate properly. The aim of the study is to see how well the study drug helps the body make the hormones necessary for ovulation and reproduction, and to assess its safety. The study is looking at several other research questions, including: * Whether the drug helps bone health * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Conditions
- Functional Hypothalamic Amenorrhea
- FHA
Interventions
MibavademabDrug
Administered per the protocol
PlaceboOther
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from the highest serum estradiol observed during a 28-day periodTime frame: Baseline to month 6
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Arensia Exploratory Medicine Clinic
Phoenix, Arizona · Recruiting
Focus Clinical Research
West Hills, California · Recruiting
Yale University School of Medicine
New Haven, Connecticut · Recruiting
Mayo Clinic Florida
Jacksonville, Florida · Recruiting
Oregon Health and Science University (OHSU)
Portland, Oregon · Recruiting
OBGYN Associates of Erie
Erie, Pennsylvania · Recruiting
Penn State Health Milton South Hershey Medical Center
Hershey, Pennsylvania · Recruiting
University of Pittsburgh
Philadelphia, Pennsylvania · Recruiting
Zillan Clinical Research
Houston, Texas · Withdrawn
University of Virginia School of Medicine
Charlottesville, Virginia · Recruiting
Tidewater Clinical Research - Tidewater Physicians for Women
Norfolk, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.